Effect of cabergoline monotherapy in Cushing's disease: an individual participant data meta-analysis.
Rajan PaluiJaya Prakash SahooSadish Kumar KamalanathanSitanshu Sekhar KarSandhiya SelvarajanH DurgiaPublished in: Journal of endocrinological investigation (2018)
This meta-analysis shows that cabergoline monotherapy is a reasonable alternative for subjects with persistent or recurrent CD after TSS. It can also be used in CD patients either as a bridge therapy while waiting for surgery or in those unwilling for surgery or have contraindication to it.
Keyphrases
- systematic review
- minimally invasive
- end stage renal disease
- coronary artery bypass
- meta analyses
- chronic kidney disease
- newly diagnosed
- ejection fraction
- combination therapy
- open label
- peritoneal dialysis
- surgical site infection
- prognostic factors
- stem cells
- clinical trial
- case control
- electronic health record
- big data
- nk cells
- machine learning
- percutaneous coronary intervention
- patient reported